Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: Remedica Ltd Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Ova-mit 50 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Light orange, round, flat scored tablets with Remedica’s logo on one side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Each tablet contains clomifene citrate 50 mg.
Excipient(s) with known effect:
This product contains 143.7 mg lactose and ponceau 4R, cochineal Red A aluminium lake E124.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Clomifene |
Clomifene is a non-steroidal agent which stimulates ovulation in a high percentage of appropriately selected anovulatory women. The ovulatory response to clomifene therapy is mediated through increased output of pituitary gonadotrophins, which in turn stimulates the maturation and endocrine activity of the ovarian follicle. |
| List of Excipients |
|---|
|
Povidone |
PVC/Aluminium blisters. Pack-size of 10 tablets.
PP containers with PE closure. Pack-sizes of 100 and 1000 tablets.
Not all pack sizes may be marketed.
Remedica Ltd Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
7874
Date of first authorization: 02 April 1981
Date of latest renewal: 05 June 2013
| Drug | Countries | |
|---|---|---|
| OVA-MIT | Cyprus, Ecuador, Hong Kong, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
